Donald J. Griffith's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 317 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sonnet BioTherapeutics Hol...
|
Donald J. Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 317 | 375 | - | - | Common Stock | |
Sonnet BioTherapeutics Hol...
|
Donald J. Griffith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 25 May 2021 | 4,235 | 95,693 | - | 1.5 | 6,395 | Common Stock |
Sonnet BioTherapeutics Hol...
|
Donald J. Griffith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 20,000 | 99,928 | - | 0 | Common Stock | |
Sonnet BioTherapeutics Hol...
|
Donald J. Griffith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 79,928 | 79,928 | - | - | Common Stock |